医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Win a Trip to Singapore With the Tiger Balm Sweepstakes

2012年11月09日 PM09:25
このエントリーをはてなブックマークに追加


 

HAYWARD, Calif.

Tiger Balm (http://tigerbalm.com/us) is inviting its fans to enter for a chance to win a trip for two to Singapore, the Home of Tiger Balm.

The Tiger Balm Singapore Sweepstakes runs through February 28, 2013. Prizes include:

  • One Grand Prize: A trip for two to Singapore, including round-trip airfare, a first-class hotel stay for 7 days and 6 nights, and a $1,000 VISA gift card (approximate retail value: $6,500).
  • Three Second Prizes: A Tiger Balm gift basket (approximate retail value: $100 each).

“Tiger Balm’s rich history dates back more than 100 years, but the company’s move to Singapore in 1926 was the catalyst to becoming one of the best-known pain-relieving brands in the world,” said Kenneth Yeung, Founder and President of Prince of Peace Enterprises, Inc. the sole licensed United States distributor for all Tiger Balm products. “The Tiger Balm Singapore Sweepstakes celebrates Tiger Balm’s heritage by giving two lucky fans the opportunity to experience Singapore’s unique blend of old-world charm and modern city vibrancy.”

Participants can enter the sweepstakes by “Liking” Tiger Balm US page on Facebook, (www.facebook.com/TigerBalmUS), and completing the online entry process. Each valid online entrant will instantly receive a $1.00 coupon good for their next in-store purchase of any Tiger Balm product.

Participants may also enter by mailing a 3” x 5” card with their clearly printed name, complete address, day and evening telephone numbers (including area code), email address (if available) and age to: Tiger Balm Singapore Sweepstakes, c/o Inception Marketing, LLC, 847 Sansome Street, Suite 200, San Francisco, CA 94111. All mail-in entries must be postmarked by February 28, 2013 and received no later than March 14, 2013 to be eligible for entry.

Each participant may enter one time, regardless of method of entry. Winners will be selected randomly from all eligible entries received, and notified on or about April 5, 2013.

The Tiger Balm Singapore Sweepstakes is open only to people twenty-one years of age or older who are legal residents and physically located in one of the fifty United States or the District of Columbia. NO PURCHASE NECESSARY TO ENTER OR WIN.

A PURCHASE DOES NOT IMPROVE YOUR CHANCES OF WINNING. Odds of winning will depend on the total number of entries received. Void where prohibited by law. For Official Rules, visit www.tigerbalm.com/us/promotions.

About Tiger Balm

Prince of Peace Enterprises, Inc. (http://tigerbalm.com/us) introduced the world-famous Tiger Balm brand to the United States mainstream market in 1986 and has been the sole licensed US distributor for all Tiger Balm products since.

Tiger Balm’s time-proven blend of herbal ingredients provides safe and effective “Pain Relief Without the Pills®” for joint and muscle strains and neck and shoulder pain, and offers convenient pain relief for just about any other minor aches and pains that may come your way.

Tiger Balm is on Facebook at https://www.facebook.com/TigerBalmUS on Twitter at https://twitter.com/tiger_balm_us, and on YouTube at http://www.youtube.com/user/TigerBalmUS.

Prince of Peace is headquartered in the heart of the San Francisco Bay Area, CA with additional branch offices in New York, Los Angeles, Hong Kong, China, and Malaysia.

CONTACT

Tiger Balm
Emilie Ko, 415-834-3190
info@mytigerbalm.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • インビボスクライブがLoui Madakamutilを治療薬部門をけん引する最高科学責任者に任命
  • Invivoscribe任命Loui Madakamutil为首席科学官,领导公司治疗学部门
  • Sonoma Pharmaceuticals and Te Arai BioFarma Announce Launch of Two New Microcyn® Technology Products in Australia – Nasocyn® Nasal Care and Oracyn® Oral Care
  • Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in Elderly Volunteers
  • S2 Genomics Announces Asia-Pacific Distribution Partnerships for the Singulator™ 100 System With SCRUM, PharmiGene, LnCBio, Thunderbio Science, and TrendBio to Accelerate Single-Cell Research